Analogues of Insulin, IGF1, and IGF2 for Studying the Biological Functions of Hormones and Their Receptors
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F25%3A00639671" target="_blank" >RIV/61388963:_____/25:00639671 - isvavai.cz</a>
Result on the web
<a href="https://hdl.handle.net/11104/0370137" target="_blank" >https://hdl.handle.net/11104/0370137</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Analogues of Insulin, IGF1, and IGF2 for Studying the Biological Functions of Hormones and Their Receptors
Original language description
Our research group at the Institute of Organic Chemistry and Biochemistry in Prague is focused on all aspects of insulin and insulin-like growth factors 1 and 2 (IGF1/2) physiology. Our general goal is to understand the structural basis for the different cellular responses triggered by insulin and IGFs. We synthesize analogs and mimetics of insulin and IGFs to study their interactions with cognate receptors and to develop new candidate drugs for the treatment of hormone-related disorders. In this lecture, I will summarize our results with insulin, IGF-1, and IGF-2 analogs that have modified binding affinities toward their cognate receptors, and I will demonstrate that these intriguing compounds can be highly useful for studying interactions and functional relationships within the insulin–IGF system, as well as for potential therapeutic applications.nThis publication was supported by the National Institute for Research on Metabolic and Cardiovascular Diseases (EXCELES Program, ID LX22NPO5104) – Funded by the European Union – Next Generation
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
<a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů